Metformin tablet formulation
Pro Research Analysisby 
Searched over 200M research papers
Immediate Release Metformin Tablet Formulation
Immediate release (IR) metformin tablets are designed for rapid onset of action, which is important for managing blood glucose levels in type 2 diabetes. Studies show that using super disintegrants like croscarmellose sodium and sodium starch glycolate in various combinations can significantly enhance drug release, with some formulations achieving up to 99.9% release within a short period . Direct compression and wet granulation are common manufacturing methods, and the choice and concentration of disintegrants and binders are key to optimizing tablet performance 12. Additionally, orodispersible tablets formulated with mannitol and super disintegrants can achieve very fast disintegration times (as low as 7.8 seconds) and high drug release rates, improving patient compliance 29.
Sustained and Modified Release Metformin Tablet Formulation
Sustained release (SR) and modified release formulations are developed to prolong the therapeutic effect of metformin, reduce dosing frequency, and improve patient adherence. Hydrophilic polymers such as hydroxypropyl methylcellulose (HPMC) in various grades (K4M, K15M, K100M) and polyvinylpyrrolidone (PVP K30) are commonly used to control drug release rates 34. Formulations with higher concentrations of HPMC K100M can sustain drug release for up to 6 hours, while blends of HPMC and PVP K30 provide optimal release kinetics and extended plasma levels for 8–12 hours 34. Natural polymers like sodium alginate and pectin are also effective in sustaining drug release, with higher polymer content further slowing the release rate .
Bilayer and Multilayer Metformin Tablet Formulations
Bilayer and multilayer tablets are designed to combine immediate and sustained release profiles or to deliver multiple drugs in a single dosage form. For example, bilayer tablets can contain an immediate release layer of another antidiabetic drug (such as glimepiride or gliclazide) and a sustained release layer of metformin 56810. These formulations use polymers like carbopol 971 and HPMC K100M to achieve prolonged mucoadhesion and controlled drug release, with some formulations sustaining metformin release for up to 12 hours 56. Tri-layered tablets can further separate incompatible drugs and optimize release profiles, using barrier layers with excipients like lactose monohydrate and microcrystalline cellulose to ensure stability and rapid disintegration .
Optimization and Evaluation of Metformin Tablet Formulations
Formulation optimization often involves systematic approaches such as central composite design and response surface methodology to balance variables like polymer concentration, excipient type, and tablet hardness 89. Key evaluation parameters include drug release rate, disintegration time, mechanical stability, and patient acceptability. Studies consistently report that optimized formulations can achieve rapid or sustained drug release as required, with good tablet integrity and compliance with pharmacopeial standards 1234+4 MORE.
Conclusion
Metformin tablet formulations can be tailored for immediate, sustained, or combined release using a variety of polymers and excipients. Immediate release tablets benefit from super disintegrants for rapid action, while sustained release and multilayer tablets use hydrophilic and natural polymers to prolong drug release and improve patient adherence. Systematic optimization and thorough evaluation ensure that these formulations meet therapeutic goals and patient needs 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic